The bone implant market is currently shaped by the aging global population and the rising incidence of osteoporosis.
The Cost-Value Shift: While 3D-printed and "smart" implants have higher upfront costs, health systems in 2026 are increasingly approving them because they reduce the "Total Cost of Care" by preventing complications and second surgeries.
Regulatory Harmonization: The EU Medical Device Regulation (MDR) and the FDA have established "fast-track" pathways for 3D-printed patient-specific devices, recognizing that for complex trauma and tumor cases, a "one-size-fits-all" approach is no longer sufficient.
1 View